Jasper Therapeutics, Inc., a biotechnology company focused on developing briquilimab, an antibody therapy for mast cell-driven diseases, announced several presentations related to briquilimab at the ...
Poster presentations may not seem as prestigious as oral presentations, but they are a great opportunity to interact with other scientists in your field in a reasonably structured way. Just like oral ...
Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx ® (secukinumab) treatment in HS to be presented New analyses of 52-week data from Phase III ...
View of industrial plant and smoke stacks at night An overview of the content at this year's American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress The 2018 ...
WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (COGT) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results